SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $360,150 | -65.7% | 17,500 | -30.0% | 0.00% | -66.7% |
| Q1 2023 | $1,049,000 | -50.4% | 25,000 | -55.0% | 0.01% | -40.0% |
| Q4 2022 | $2,116,770 | +77.3% | 55,500 | +82.0% | 0.01% | +66.7% |
| Q3 2022 | $1,194,000 | +28.7% | 30,500 | +6.1% | 0.01% | +50.0% |
| Q2 2022 | $928,000 | -42.0% | 28,740 | -40.5% | 0.00% | -33.3% |
| Q1 2022 | $1,599,000 | +5230.0% | 48,299 | +9064.9% | 0.01% | – |
| Q2 2021 | $30,000 | -59.5% | 527 | -46.7% | 0.00% | – |
| Q1 2021 | $74,000 | – | 988 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |